GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lantheus Holdings Inc (FRA:0L8) » Definitions » Pre-Tax Income

Lantheus Holdings (FRA:0L8) Pre-Tax Income : €549 Mil (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Lantheus Holdings Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Lantheus Holdings's pretax income for the three months ended in Mar. 2024 was €158 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was €549 Mil. Lantheus Holdings's pretax margin was 46.29%.

During the past 13 years, Lantheus Holdings's highest Pretax Margin was 43.45%. The lowest was -17.65%. And the median was 5.55%.


Lantheus Holdings Pre-Tax Income Historical Data

The historical data trend for Lantheus Holdings's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lantheus Holdings Pre-Tax Income Chart

Lantheus Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.76 -9.44 -66.41 25.22 376.84

Lantheus Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.37 114.16 149.88 126.92 157.57

Competitive Comparison of Lantheus Holdings's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Lantheus Holdings's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lantheus Holdings's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lantheus Holdings's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Lantheus Holdings's Pre-Tax Income falls into.



Lantheus Holdings Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Lantheus Holdings's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=334.377+42.807+-18.357+18.008+0
=377

Lantheus Holdings's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=92.351+61.822+-4.47+7.864+0
=158

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €549 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lantheus Holdings  (FRA:0L8) Pre-Tax Income Explanation

Lantheus Holdings's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=157.567/340.377
=46.29%

During the past 13 years, Lantheus Holdings's highest Pretax Margin was 43.45%. The lowest was -17.65%. And the median was 5.55%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lantheus Holdings Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Lantheus Holdings's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Lantheus Holdings (FRA:0L8) Business Description

Traded in Other Exchanges
Address
201 Burlington Road, South Building, Bedford, MA, USA, 01730
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Lantheus Holdings (FRA:0L8) Headlines

No Headlines